By www.reliablemarketforecast.com
Global Idiopathic Pulmonary Fibrosis Treatment Market Research Report 2023 Story
85
$ 2900
Idiopathic Pulmonary Fibrosis Treatment Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Biogen Boehringer Ingelheim GMBH Bristol-Myers Squibb Company Cipla Hoffmann-La Roche AG Fibrogen, Inc. Galapagos NV Medicinova, Inc. Merck & Co., Inc. Novartis AG Prometic Life Sciences Inc.